(NasdaqGM:XOMA),(NasdaqGM:XOMAO),(NasdaqGM:XOMAP), Business development: Secures royalty economic interests in two early stage partnered assets through XOMA Royalty's announced expected acquisition of LAVA Therapeutics. Company acquisitions: •Completed XOMA Royalty's acquisitions of Turnstone Biologics and HilleVax; • announced acquisitions of LAVA Therapeutics and Mural Oncology; • acted as structuring agent for XenoTherapeutics' acquisition of ESSA Pharma. Key Pipeline […]

(NASDAQ:ABEO), – First anticipated ZEVASKYN(R) patient treatment shifted to 4Q 2025 following implementation of optimized release assay – – Strong and growing patient demand and treatment site network, along with broad market access provide foundation for sustainable commercial success – – $207.5M in cash, cash equivalents, restricted cash and short-term investments as of September 30,

(CNSX:TCEC.CN),(OTC US:TCEFF),(Other OTC:TCEFF),(Boerse Frankfurt – Freiverkehr:C9O0), Vancouver B.C., Nov. 12, 2025 (GLOBE NEWSWIRE) — TERRA CLEAN ENERGY CORP. (“Terra” or the “Company“) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0), is pleased to announce that, further to its press release dated September 24, 2025, the Company has issued a total of 750,000 common shares to the current

(NASDAQ:LTRX), IRVINE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced that its CEO Saleel Awsare will participate in three upcoming investor conferences: 16th Annual Craig-Hallum Alpha Select Conference — Tuesday, Nov. 18, New York City One-on-one meetings

Washington, D.C., Nov. 12, 2025 (GLOBE NEWSWIRE) — Forterra, the company redefining autonomy and mission system interoperability for defense and logistics, today announced it closed a $238 million Series C in equity and debt. The round was led by Moore Strategic Ventures, joined by new investors including Salesforce Ventures, Franklin Templeton, Balyasny Asset Management, 645

(TSX-V:BBB),(OTC US:BBBXF),(Other OTC:BBBXF), VANCOUVER, British Columbia, Nov. 12, 2025 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton“) is pleased to announce additional drill results from the Trapper Gold Target from the 2025 season. High-grade intervals were observed, in cases accompanied by visible gold. A total of 6272m was drilled

IRVINE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Habit is celebrating its 56th birthday the best way it knows how: by giving back. On Saturday, November 15, guests nationwide are invited to join Good Habits Day, a one-day event where doing good never tasted so good. With a $1+ donation to No Kid Hungry and

(NASDAQ:PYPD), Face-to-Face Pre-NDA Meeting with the FDA Scheduled for Early December; NDA Submission for D-PLEXâ‚₀₀ On Track for Early 2026 Advancements in Discussions with Potential U.S. Partners Following Positive Phase 3 Trial Results Company Continues to Advance Towards Commercial Manufacturing Readiness with Successful Completion of IMOH GMP Inspection Conference Call Scheduled for Today at 8:30

(NYSE MKT:PHGE), Positive FDA feedback confirms clear clinical pathway for BX011 targeting S. aureus in Diabetic Foot Infections, building on Company's prior Phase 2 success BiomX expects FDA feedback on BX004 clinical hold imminently; Enrollment and dosing of patients outside the U.S. are continuing in accordance with protocol Positive FDA feedback received in October provided

DeFiTechnologies Inc. (the “Company” or “DeFi Technologies”) (the “Company” or “DeFi Technologies”) (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance (“DeFi”), today announced it will hold a shareholder call on Friday, November 14, 2025, at 12:00 p.m. EST to discuss its financial